Avoiding mouse traps in schizophrenia genetics: Lessons and promises from current and emerging mouse models

Neuroscience

Volumn 211, Issue , 2012, Pages 136-164

  Kvajo, M ^a   McKellar, H ^b   Gogos, J A ^a,b  

^a Columbia University Medical Center ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Candidate genes; Common variants; Disease models; Mouse models; Rare mutations; Schizophrenia

Indexed keywords

ALLELE; CHROMOSOME DELETION 22Q11; COGNITIVE DEFECT; DISC1 GENE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HETEROZYGOTE; MOLECULAR EVOLUTION; MOUSE; NEGATIVE SYNDROME; NONHUMAN; NRG1 GENE; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; POSITIVE SYNDROME; PRIORITY JOURNAL; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; GENETIC ASSOCIATION STUDIES; HUMANS; MICE; SCHIZOPHRENIA;

EID: 84860639057     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.051     Document Type: Review

References (231)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40:827-834.
2. Amann-Zalcenstein D., Avidan N., Kanyas K., Ebstein R.P., Kohn Y., Hamdan A., Ben-Asher E., Karni O., Mujaheed M., Segman R.H., Maier W., Macciardi F., Beckmann J.S., Lancet D., Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet 2006, 14:1111-1119.
3. Anholt R.R., Dilda C.L., Chang S., Fanara J.J., Kulkarni N.H., Ganguly I., Rollmann S.M., Kamdar K.P., Mackay T.F. The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome. Nat Genet 2003, 35:180-184.
4. Arguello P.A., Gogos J.A. Modeling madness in mice: one piece at a time. Neuron 2006, 52:179-196.
5. Arguello P.A., Gogos J.A. Cognition in mouse models of schizophrenia susceptibility genes. Schizophr Bull 2010, 36:289-300.
6. Arinami T., Yamada N., Yamakawa-Kobayashi K., Hamaguchi H., Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 1997, 74:526-528.
7. Austin C.P., Ky B., Ma L., Morris J.A., Shughrue P.J. Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 2004, 124:3-10.
8. Ayhan Y., Abazyan B., Nomura J., Kim R., Ladenheim B., Krasnova I.N., Sawa A., Margolis R.L., Cadet J.L., Mori S., Vogel M.W., Ross C.A., Pletnikov M.V. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry 2011, 16:293-306.
9. Balu D.T., Carlson G.C., Talbot K., Kazi H., Hill-Smith T.E., Easton R.M., Birnbaum M.J., Lucki I. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus 2010, Epub ahead of print.
10. Barakat A., Dean B., Scarr E., Evin G. Decreased neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophr Res 2010, 124:200-207.
11. Barnea-Goraly N., Menon V., Krasnow B., Ko A., Reiss A., Eliez S. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am J Psychiatry 2003, 160:1863-1869.
12. Barros C.S., Calabrese B., Chamero P., Roberts A.J., Korzus E., Lloyd K., Stowers L., Mayford M., Halpain S., Müller U. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc Natl Acad Sci U S A 2009, 106:4507-4512.
13. Bayés A., van de Lagemaat L.N., Collins M.O., Croning M.D., Whittle I.R., Choudhary J.S., Grant S.G. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 2011, 14:19-21.
14. Bearden C.E., van Erp T.G., Dutton R.A., Lee A.D., Simon T.J., Cannon T.D., Emanuel B.S., Donald-McGinn D., Zackai E.H., Thompson P.M. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q112 deletions. Cereb Cortex 2009, 19:115-126.
15. Bearden C.E., Woodin M.F., Wang P.P., Moss E., Donald-McGinn D., Zackai E., Emannuel B., Cannon T.D. The neurocognitive phenotype of the 22q112 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 2001, 23:447-464.
16. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., Borrelli E., Caron M.G. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007, 27:881-885.
17. Bender H.U., Almashanu S., Steel G., Hu C.A., Lin W.W., Willis A., Pulver A., Valle D. Functional consequences of PRODH missense mutations. Am J Hum Genet 2005, 76:409-420.
18. Bertram I., Bernstein H.G., Lendeckel U., Bukowska A., Dobrowolny H., Keilhoff G., Kanakis D., Mawrin C., Bielau H., Falkai P., Bogerts B. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Ann N Y Acad Sci 2007, 1096:147-156.
19. Blasi G., Bertolino A. Imaging genomics and response to treatment with antipsychotics in schizophrenia. Neurorx 2006, 3:117-130.
20. Blednov Y.A., Jung S., Alva H., Wallace D., Rosahl T., Whiting P.J., Harris R.A. Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs. J Pharmacol Exp Ther 2003, 304:30-36.
21. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
22. Brinkmeier M.L., Potok M.A., Davis S.W., Camper S.A. TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 2007, 311:396-407.
23. Brzózka M.M., Radyushkin K., Wichert S.P., Ehrenreich H., Rossner M.J. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 2010, 68:33-40.
24. Burdick K.E., Hodgkinson C.A., Szeszko P.R., Lencz T., Ekholm J.M., Kane J.M., Goldman D., Malhotra A.K. DISC1 and neurocognitive function in schizophrenia. Neuroreport 2005, 16:1399-1402.
25. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 2005, 102:8627-8632.
26. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., Kaprio J., Mazziotta J., Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 2005, 62:1205-1213.
27. Cao L., Dhilla A., Mukai J., Blazeski R., Lodovichi C., Mason C.A., Gogos J.A. Genetic modulation of BDNF signaling affects the outcome of axonal competition in vivo. Curr Biol 2007, 17:911-921.
28. Chalifoux J.R., Carter A.G. GABAB receptors modulate NMDA receptor calcium signals in dendritic spines. Neuron 2010, 66:101-113.
29. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
30. Chen Q.Y., Chen Q., Feng G.Y., Lindpaintner K., Wang L.J., Chen Z.X., Gao Z.S., Tang J.S., Huang G., He L. Case-control association study of Disrupted-in-Schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population. J Psychiatr Res 2007, 41:428-434.
31. Chen Y., Hancock M.L., Role L.W., Talmage D.A. Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J Neurosci 2010, 30:9199-9208.
32. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
33. Chen X., Lee G., Maher B.S., Fanous A.H., Chen J., Zhao Z., Guo A., van den O.E., Sullivan P.F., Shi J., Levinson D.F., Gejman P.V., Sanders A., Duan J., Owen M.J., Craddock N.J., O'Donovan M.C., Blackman J., Lewis D., Kirov G.K., Qin W., Schwab S., Wildenauer D., Chowdari K., Nimgaonkar V., Straub R.E., Weinberger D.R., O'Neill F.A., Walsh D., Bronstein M., Darvasi A., Lencz T., Malhotra A.K., Rujescu D., Giegling I., Werge T., Hansen T., Ingason A., Noethen M.M., Rietschel M., Cichon S., Djurovic S., Andreassen O.A., Cantor R.M., Ophoff R., Corvin A., Morris D.W., Gill M., Pato C.N., Pato M.T., Macedo A., Gurling H.M., McQuillin A., Pimm J., Hultman C., Lichtenstein P., Sklar P., Purcell S.M., Scolnick E., St C.D., Blackwood D.H., Kendler K.S. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry 2010, Epub ahead of Print.
34. Chong V.Z., Thompson M., Beltaifa S., Webster M.J., Law A.J., Weickert C.S. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008, 100:270-280.
35. Chow E.W., Watson M., Young D.A., Bassett A.S. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 2006, 87:270-278.
36. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., Thelma B.K., Ferrell R.E., Middleton F.A., Devlin B., Levitt P., Lewis D.A., Nimgaonkar V.L. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002, 11:1373-1380.
37. Chubb J.E., Bradshaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC locus in psychiatric illness. Mol Psychiatry 2008, 13:36-64.
38. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., urich-Costa J., Cherif D., Gimalac A., Van D.C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
39. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425.
40. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., Roder J.C. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54:387-402.
41. Corfas G., Roy K., Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004, 7:575-580.
42. Cutler D.J., Haraura M., Reed H.E., Shen S., Sheward W.J., Morrison C.F., Marston H.M., Harmar A.J., Piggins H.D. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro. Eur J Neurosci 2003, 17:197-204.
43. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
44. Daskalakis Z.J., Fitzgerald P.B., Christensen B.K. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res Rev 2007, 56:427-442.
45. Dawe G.S., Hwang E.H., Tan C.H. Pathophysiology and animal models of schizophrenia. Ann Acad Med Singapore 2009, 38:425-426.
46. Deakin I.H., Law A.J., Oliver P.L., Schwab M.H., Nave K.A., Harrison P.J., Bannerman D.M. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 2009, 20:1523-1528.
47. Dean B., Karl T., Pavey G., Boer S., Duffy L., Scarr E. Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. Schizophr Res 2008, 99:341-349.
48. Devon R.S., Anderson S., Teague P.W., Burgess P., Kipari T.M., Semple C.A., Millar J.K., Muir W.J., Murray V., Pelosi A.J., Blackwood D.H., Porteous D.J. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet 2001, 11:71-78.
49. Di Giorgio A., Blasi G., Sambataro F., Rampino A., Papazacharias A., Gambi F., Romano R., Caforio G., Rizzo M., Latorre V., Popolizio T., Kolachana B., Callicott J.H., Nardini M., Weinberger D.R., Bertolino A. Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci 2008, 28:2129-2136.
50. Dickson L., Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol Ther 2009, 121:294-316.
51. Díez-Guerra F.J. Neurogranin, a link between calcium/calmodulin and protein kinase C signaling in synaptic plasticity. IUBMB Life 2010, 62:597-606.
52. Drew L.J., Crabtree G.W., Markx S., Stark K.L., Chaverneff F., Xu B., Mukai J., Fenelon K., Hsu P.K., Gogos J.A., Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci 2011, 29:259-281.
53. Drew L.J., Stark K.L., Fenelon K., Karayiorgou M., Macdermott A.B., Gogos J.A. Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Mol Cell Neurosci 2011, 47:293-305.
54. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake Y., Liu X.B., Yang C.H., Jordan J.D., Ma D.K., Liu C.Y., Ganesan S., Cheng H.J., Ming G.L., Lu B., Song H. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007, 130:1146-1158.
55. Earls L.R., Bayazitov I.T., Fricke R.G., Berry R.B., Illingworth E., Mittleman G., Zakharenko S.S. Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome. J Neurosci 2010, 30:15843-15855.
56. Ehrlichman R.S., Luminais S.N., White S.L., Rudnick N.D., Ma N., Dow H.C., Kreibich A.S., Abel T., Brodkin E.S., Hahn C.G., Siegel S.J. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res 2009, 1294:116-127.
57. El-Husseini Ael-D., Bredt D.S. Protein palmitoylation: a regulator of neuronal development and function. Nat Rev Neurosci 2002, 3:791-802.
58. Eliez S., Blasey C.M., Schmitt E.J., White C.D., Hu D., Reiss A.L. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?. Am J Psychiatry 2001, 158:447-453.
59. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004, 36:131-137.
60. Enomoto A., Asai N., Namba T., Wang Y., Kato T., Tanaka M., Tatsumi H., Taya S., Tsuboi D., Kuroda K., Kaneko N., Sawamoto K., Miyamoto R., Jijiwa M., Murakumo Y., Sokabe M., Seki T., Kaibuchi K., Takahashi M. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 2009, 63:774-787.
61. Faulkner R.L., Jang M.H., Liu X.B., Duan X., Sailor K.A., Kim J.Y., Ge S., Jones E.G., Ming G.L., Song H., Cheng H.J. Development of hippocampal mossy fiber synaptic outputs by new neurons in the adult brain. Proc Natl Acad Sci U S A 2008, 105:14157-14162.
62. Fénelon K., Mukai J., Xu B., Hsu P.K., Drew L.J., Karayiorgou M., Fischbach G.D., Macdermott A.B., Gogos J.A. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 2011, 108:4447-4452.
63. Flores A.I., Mallon B.S., Matsui T., Ogawa W., Rosenzweig A., Okamoto T., Macklin W.B. Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 2000, 20:7622-7630.
64. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., Davis K.L., Silverman J.M., Brunner H.G., van Kessel A.G., Wijmenga C., Ophoff R.A., Veltman J.A. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008, 13:261-266.
65. Gassmann M., Lemke G. Neuregulins and neuregulin receptors in neural development. Curr Opin Neurobiol 1997, 7:87-92.
66. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 2003, 100:8993-8998.
67. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
68. Glessner J.T., Reilly M.P., Kim C.E., Takahashi N., Albano A., Hou C., Bradfield J.P., Zhang H., Sleiman P.M., Flory J.H., Imielinski M., Frackelton E.C., Chiavacci R., Thomas K.A., Garris M., Otieno F.G., Davidson M., Weiser M., Reichenberg A., Davis K.L., Friedman J.I., Cappola T.P., Margulies K.B., Rader D.J., Grant S.F., Buxbaum J.D., Gur R.E., Hakonarson H. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A 2010, 107:10584-10589.
69. Gogos J.A., Gerber D.J. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006, 27:226-233.
70. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 1998, 95:9991-9996.
71. Gogos J.A., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., Nadler J.V., Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 1999, 21:434-439.
72. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., Kwon H., Jin S., Jo B., Antonarakis S.E., Morris M.A., Reiss A.L. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 2005, 8:1500-1502.
73. Gothelf D., Feinstein C., Thompson T., Gu E., Penniman L., Van Stone E., Kwon H., Eliez S., Reiss A.L. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 2007, 164:663-669.
74. Govek E.E., Newey S.E., Akerman C.J., Cross J.R., van der Veken L., van Aelst L. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat Neurosci 2004, 7:364-372.
75. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
76. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull 2000, 26:119-136.
77. Greengard P., Nairn A.C., Girault J.A., Ouimet C.C., Snyder G.L., Fisone G., Allen P.B., Fienberg A., Nishi A. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Res Brain Res Rev 1998, 26:274-284.
78. Groneberg D.A., Rabe K.F., Fischer A. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol 2006, 533:182-194.
79. Harmar A.J., Marston H.M., Shen S., Spratt C., West K.M., Sheward W.J., Morrison C.F., Dorin J.R., Piggins H.D., Reubi J.C., Kelly J.S., Maywood E.S., Hastings M.H. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 2002, 109:497-508.
80. Hashimoto R., Straub R.E., Weickert C.S., Hyde T.M., Kleinman J.E., Weinberger D.R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004, 9:299-307.
81. Hayesmoore J.B., Bray N.J., Owen M.J., O'Donovan M.C. DISC1 mRNA expression is not influenced by common cis-acting regulatory polymorphisms or imprinting. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1065-1069.
82. Hennah W., Tuulio-Henriksson A., Paunio T., Ekelund J., Varilo T., Partonen T., Cannon T.D., Lönnqvist J., Peltonen L. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol Psychiatry 2005, 10:1097-1103.
83. Hennah W., Thomson P., McQuillin A., Bass N., Loukola A., Anjorin A., Blackwood D., Curtis D., Deary I.J., Harris S.E., Isometsa E.T., Lawrence J., Lonnqvist J., Muir W., Palotie A., Partonen T., Paunio T., Pylkko E., Robinson M., Soronen P., Suominen K., Suvisaari J., Thirumalai S., St Clair D., Gurling H., Peltonen L., Porteous D. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry 2009, 14:865-873.
84. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andradé M., Tankou S., Mori S., Gallagher M., Ishizuka K., Pletnikov M., Kida S., Sawa A. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 2007, 104:14501-14506.
85. Ho G.P., Selvakumar B., Mukai J., Hester L.D., Wang Y., Gogos J.A., Snyder S.H. S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 2011, 71:131-141.
86. Hong C.J., Tsai S.J., Wang Y.C. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res 2001, 49:59-63.
87. Hong C.J., Huo S.J., Liao D.L., Lee K., Wu J.Y., Tsai S.J. Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neurosci Lett 2004, 366:158-161.
88. Hsu R., Woodroffe A., Lai W.S., Cook M.N., Mukai J., Dunning J.P., Swanson D.J., Roos J.L., Abecasis G.R., Karayiorgou M., Gogos J.A. Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS ONE 2007, 2:e1234.
89. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26:443-455.
90. Ide M., Lewis D.A. Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry 2010, 68:25-32.
91. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241. International Schizophrenia Consortium.
92. Ishikawa T., Gotoh N., Murayama C., Abe T., Iwashita M., Matsuzaki F., Suzuki T., Yamamoto T. IgSF molecule MDGA1 is involved in radial migration and positioning of a subset of cortical upper-layer neurons. Dev Dyn 2011, 240:96-107.
93. Ishizuka K., Chen J., Taya S., Li W., Millar J.K., Xu Y., Clapcote S.J., Hookway C., Morita M., Kamiya A., Tomoda T., Lipska B.K., Roder J.C., Pletnikov M., Porteous D., Silva A.J., Cannon T.D., Kaibuchi K., Brandon N.J., Weinberger D.R., Sawa A. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry 2007, 12:897-899.
94. Jacquet H., Demily C., Houy E., Hecketsweiler B., Bou J., Raux G., Lerond J., Allio G., Haouzir S., Tillaux A., Bellegou C., Fouldrin G., Delamillieure P., Ménard J.F., Dollfus S., D'Amato T., Petit M., Thibaut F., Frébourg T., Campion D. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 2005, 10:479-485.
95. Jentsch J.D., Trantham-Davidson H., Jairl C., Tinsley M., Cannon T.D., Lavin A. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 2009, 34:2601-2608.
96. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001, 27:286-291.
97. Kahler A.K., Djurovic S., Kulle B., Jonsson E.G., Agartz I., Hall H., Opjordsmoen S., Jakobsen K.D., Hansen T., Melle I., Werge T., Steen V.M., Andreassen O.A. Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 147B 2008, 1089-1100.
98. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005, 7:1167-1178.
99. Kao S.C., Wu H., Xie J., Chang C.P., Ranish J.A., Graef I.A., Crabtree G.R. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 2009, 323:651-654.
100. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 1995, 92:7612-7616.
101. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010, 11:402-416.
102. Karl T., Duffy L., Scimone A., Harvey R.P., Schofield P.R. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav 2007, 6:677-687.
103. Kates W.R., Krauss B.R., Abdulsabur N., Colgan D., Antshel K.M., Higgins A.M., Shprintzen R.J. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Neuropsychologia 2007, 45:2863-2873.
104. Kato T., Kasai A., Mizuno M., Fengyi L., Shintani N., Maeda S., Yokoyama M., Ozaki M., Nawa H. Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS ONE 2010, 5:e14185.
105. Kellendonk C., Simpson E.H., Polan H.J., Malleret G., Vronskaya S., Winiger V., Moore H., Kandel E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006, 49:603-615.
106. Khelfaoui M., Denis C., van Galen E., de Bock F., Schmitt A., Houbron C., Morice E., Giros B., Ramakers G., Fagni L., Chelly J., Nosten-Bertrand M., Billuart P. Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci 2007, 27:9439-9450.
107. Kim H.J., Park H.J., Jung K.H., Ban J.Y., Ra J., Kim J.W., Park J.K., Choe B.K., Yim S.V., Kwon Y.K., Chung J.H. Association study of polymorphisms between DISC1 and schizophrenia in a Korean population. Neurosci Lett 2008, 430:60-63.
108. Kim J.Y., Duan X., Liu C.Y., Jang M.H., Guo J.U., Pow-anpongkul N., Kang E., Song H., Ming G.L. DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron 2009, 63:761-773.
109. Kimber W.L., Hsieh P., Hirotsune S., Yuva-Paylor L., Sutherland H.F., Chen A., Ruiz-Lozano P., Hoogstraten-Miller S.L., Chien K.R., Paylor R., Scambler P.J., Wynshaw-Boris A. Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum Mol Genet 1999, 8:2229-2237.
110. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc Natl Acad Sci U S A 2006, 103:3693-3697.
111. Kramer P.F., Christensen C.H., Hazelwood L.A., Dobi A., Bock R., Sibley D.R., Mateo Y., Alvarez V.A. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J Neurosci 2011, 31:126-132.
112. Kubo K., Tomita K., Uto A., Kuroda K., Seshadri S., Cohen J., Kaibuchi K., Kamiya A., Nakajima K. Migration defects by DISC1 knockdown in C57BL/6, 129X1/SvJ, and ICR strains via in utero gene transfer and virus-mediated RNAi. Biochem Biophys Res Commun 2010, 400:631-637.
113. Kvajo M., McKellar H., Arguello P.A., Drew L.J., Moore H., Macdermott A.B., Karayiorgou M., Gogos J.A. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci U S A 2008, 105:7076-7081.
114. Kvajo M., McKellar H., Gogos J.A. Molecules, signaling, and schizophrenia. Curr Top Behav Neurosci 2010, 4:629-656.
115. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007, 16:129-141.
116. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A 2006, 103:6747-6752.
117. Lee F.H., Fadel M.P., Preston-Maher K., Cordes S.P., Clapcote S.J., Price D.J., Roder J.C., Wong A.H. Disc1 point mutations in mice affect development of the cerebral cortex. J Neurosci 2011, 31:3197-3206.
118. Levav-Rabkin T., Blumkin E., Galron D., Golan H.M. Sex-dependent behavioral effects of Mthfr deficiency and neonatal GABA potentiation in mice. Behav Brain Res 2011, 216:505-513.
119. Li T., Ma X., Hu X., Wang Y., Yan C., Meng H., Liu X., Toulopoulou T., Murray R.M., Collier D.A. PRODH gene is associated with executive function in schizophrenic families. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:654-657.
120. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lönnqvist J., Huttunen M.O., Kaprio J., Trachtenberg J.T., Silva A.J., Cannon T.D. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A 2007, 104:18280-18285.
121. Lim S.M., Kim H.J., Nam M., Chung J.H., Park Y.H. Association study of DISC1 in Korean population with autism spectrum disorders. Psychiatr Genet 2009, 19:160.
122. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410:97-101.
123. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000, 23:223-239.
124. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., Larson J., Condie B.G., Guidotti A., Costa E. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci U S A 2001, 98:3477-3482.
125. Liu Y.L., Fann C.S., Liu C.M., Chen W.J., Wu J.Y., Hung S.I., Chen C.H., Jou Y.S., Liu S.K., Hwang T.J., Hsieh M.H., Ouyang W.C., Chan H.Y., Chen J.J., Yang W.C., Lin C.Y., Lee S.F., Hwu H.G. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol Psychiatry 2006, 60:554-562.
126. Lo W.S., Lau C.F., Xuan Z., Chan C.F., Feng G.Y., He L., Cao Z.C., Liu H., Luan Q.M., Xue H. Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol Psychiatry 2004, 9:603-608.
127. Loe-Mie Y., Lepagnol-Bestel A.M., Maussion G., Doron-Faigenboim A., Imbeaud S., Delacroix H., Aggerbeck L., Pupko T., Gorwood P., Simonneau M., Moalic J.M. SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum Mol Genet 2010, 19:2841-2857.
128. Long J.M., LaPorte P., Merscher S., Funke B., Saint-Jore B., Puech A., Kucherlapati R., Morrow B.E., Skoultchi A.I., Wynshaw-Boris A. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 2006, 7:247-257.
129. Malleret G., Haditsch U., Genoux D., Jones M.W., Bliss T.V., Vanhoose A.M., Weitlauf C., Kandel E.R., Winder D.G., Mansuy I.M. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 2001, 104:675-686.
130. Mansuy I.M., Mayford M., Jacob B., Kandel E.R., Bach M.E. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 1998, 92:39-49.
131. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
132. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
133. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., Perkins D.O., Dickel D.E., Kusenda M., Krastoshevsky O., Krause V., Kumar R.A., Grozeva D., Malhotra D., Walsh T., Zackai E.H., Kaplan P., Ganesh J., Krantz I.D., Spinner N.B., Roccanova P., Bhandari A., Pavon K., Lakshmi B., Leotta A., Kendall J., Lee Y.H., Vacic V., Gary S., Iakoucheva L.M., Crow T.J., Christian S.L., Lieberman J.A., Stroup T.S., Lehtimäki T., Puura K., Haldeman-Englert C., Pearl J., Goodell M., Willour V.L., DeRosse P., Steele J., Kassem L., Wolff J., Chitkara N., McMahon F.J., Malhotra A.K., Potash J.B., Schulze T.G., Nothen M.M., Cichon S., Rietschel M., Leibenluft E., Kustanovich V., Lajonchere C.M., Sutcliffe J.S., Skuse D., Gill M., Gallagher L., Mendell N.R., Craddock N., Owen M.J., O'Donovan M.C., Shaikh T.H., Susser E., DeLisi L.E., Sullivan P.F., Deutsch C.K., Rapoport J., Levy D.L., King M.C., Sebat J. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009, 41:1223-1227.
134. McClellan J., King M.C. Genetic heterogeneity in human disease. Cell 2010, 141:210-217.
135. Meechan D.W., Tucker E.S., Maynard T.M., Lamantia A.S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc Natl Acad Sci U S A 2009, 106:16434-16445.
136. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., Xavier R.J., Demay M.B., Russell R.G., Factor S., Tokooya K., Jore B.S., Lopez M., Pandita R.K., Lia M., Carrion D., Xu H., Schorle H., Kobler J.B., Scambler P., Wynshaw-Boris A., Skoultchi A.I., Morrow B.E., Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
137. Meyer D., Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995, 378:386-390.
138. Meyer K.D., Morris J.A. Disc1 regulates granule cell migration in the developing hippocampus. Hum Mol Genet 2009, 18:3286-3297.
139. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 2010, 90:285-326.
140. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
141. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000, 9:1415-1423.
142. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
143. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 2006, 60:253-264.
144. Mukai J., Dhilla A., Drew L.J., Stark K.L., Cao L., Macdermott A.B., Karayiorgou M., Gogos J.A. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat Neurosci 2008, 11:1302-1310.
145. Mukai J., Liu H., Burt R.A., Swor D.E., Lai W.S., Karayiorgou M., Gogos J.A. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004, 36:725-731.
146. Murphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940-945.
147. Nakata K., Lipska B.K., Hyde T.M., Ye T., Newburn E.N., Morita Y., Vakkalanka R., Barenboim M., Sei Y., Weinberger D.R., Kleinman J.E. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci U S A 2009, 106:15873-15878.
148. Nave K.A., Salzer J.L. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol 2006, 16:492-500.
149. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
150. Newton-Cheh C., Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005, 573:54-69.
151. Nicodemus K.K., Law A.J., Luna A., Vakkalanka R., Straub R.E., Kleinman J.E., Weinberger D.R. A 5' promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. Mol Psychiatry 2009, 14:741-743.
152. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Möller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055.
153. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011, 16:286-292.
154. Otte D.M., Bilkei-Gorzó A., Filiou M.D., Turck C.W., Yilmaz O., Holst M.I., Schilling K., Abou-Jamra R., Schumacher J., Benzel I., Kunz W.S., Beck H., Zimmer A. Behavioral changes in G72/G30 transgenic mice. Eur Neuropsychopharmacol 2009, 19:339-348.
155. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., Harvey R., Waddington J.L. Phenotypic characterization of spatial cognition and social behavior in mice with "knockout" of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147:18-27.
156. O'Tuathaigh C.M., Harte M., O'Leary C., O'Sullivan G.J., Blau C., Lai D., Harvey R.P., Tighe O., Fagan A.J., Kerskens C., Reynolds G.P., Waddington J.L. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 "knockout" mice. Eur J Neurosci 2010, 31:349-358.
157. O'Tuathaigh C.M., O'Connor A.M., O'Sullivan G.J., Lai D., Harvey R., Croke D.T., Waddington J.L. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous "knockout" of the schizophrenia risk gene neuregulin-1. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:462-466.
158. O'Tuathaigh C.M., O'Sullivan G.J., Kinsella A., Harvey R.P., Tighe O., Croke D.T., Waddington J.L. Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 2006, 17:79-83.
159. Owen M.J., Craddock N., O'Donovan M.C. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch Gen Psychiatry 2010, 67:667-673.
160. Pacey L.K., Doss L., Cifelli C., van der Kooy D., Heximer S.P., Hampson D.R. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse. Mol Cell Neurosci 2011, 46:563-572.
161. Pak J.H., Huang F.L., Li J., Balschun D., Reymann K.G., Chiang C., Westphal H., Huang K.P. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc Natl Acad Sci U S A 2000, 97:11232-11237.
162. Palmer A.A., Low M.J., Grandy D.K., Phillips T.J. Effects of a Drd2 deletion mutation on ethanol-induced locomotor stimulation and sensitization suggest a role for epistasis. Behav Genet 2003, 33:311-324.
163. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008, 28:8709-8723.
164. Paterlini M., Zakharenko S.S., Lai W.S., Qin J., Zhang H., Mukai J., Westphal K.G., Olivier B., Sulzer D., Pavlidis P., Siegelbaum S.A., Karayiorgou M., Gogos J.A. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 2005, 8:1586-1594.
165. Paylor R., McIlwain K.L., McAninch R., Nellis A., Yuva-Paylor L.A., Baldini A., Lindsay E.A. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet 2001, 10:2645-2650.
166. Paylor R., Glaser B., Mupo A., Ataliotis P., Spencer C., Sobotka A., Sparks C., Choi C.H., Oghalai J., Curran S., Murphy K.C., Monks S., Williams N., O'Donovan M.C., Owen M.J., Scambler P.J., Lindsay E. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A 2006, 103:7729-7734.
167. Pickard B.S., Thomson P.A., Christoforou A., Evans K.L., Morris S.W., Porteous D.J., Blackwood D.H., Muir W.J. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 2007, 17:129-133.
168. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008, 13:173-186.
169. Pletnikov M.V., Ayhan Y., Xu Y., Nikolskaia O., Ovanesov M., Huang H., Mori S., Moran T.H., Ross C.A. Enlargement of the lateral ventricles in mutant DISC1 transgenic mice. Mol Psychiatry 2008, 13:115.
170. Popa D., Léna C., Fabre V., Prenat C., Gingrich J., Escourrou P., Hamon M., Adrien J. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J Neurosci 2005, 25:11231-11238.
171. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Kravariti E., Toulopoulou T., Miorelli A., Murray R., Collier D.A., McGuire P.K. Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol Psychiatry 2008, 13:915-917. 909.
172. Pritchard J.K., Cox N.J. The allelic architecture of human disease genes: common disease-common variant. . .or not?. Hum Mol Genet 2002, 11:2417-2423.
173. Pulver A.E., Nestadt G., Goldberg R., Shprintzen R.J., Lamacz M., Wolyniec P.S., Morrow B., Karayiorgou M., Antonarakis S.E., Housman D. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994, 182:476-478.
174. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
175. Raux G., Bumsel E., Hecketsweiler B., van Amelsvoort T., Zinkstok J., Manouvrier-Hanu S., Fantini C., Brévière G.M., Di Rosa G., Pustorino G., Vogels A., Swillen A., Legallic S., Bou J., Opolczynski G., Drouin-Garraud V., Lemarchand M., Philip N., Gérard-Desplanches A., Carlier M., Philippe A., Nolen M.C., Heron D., Sarda P., Lacombe D., Coizet C., Alembik Y., Layet V., Afenjar A., Hannequin D., Demily C., Petit M., Thibaut F., Frebourg T., Campion D. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 2007, 16:83-91.
176. Rebbeck T.R., Spitz M., Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 2004, 5:589-597.
177. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999, 1451:1-16.
178. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 2005, 16:271-275.
179. Roussos P., Giakoumaki S.G., Adamaki E., Bitsios P. The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol Psychiatry 2011, 69:479-486.
180. Roy K., Murtie J.C., El-Khodor B.F., Edgar N., Sardi S.P., Hooks B.M., Benoit-Marand M., Chen C., Moore H., O'Donnell P., Brunner D., Corfas G. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 2007, 104:8131-8136.
181. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., Fang Y., Larson J.L., McDougall J.A., Chester J.A., Saez C., Pugsley T.A., Gershanik O., Low M.J., Grandy D.K. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997, 90:991-1001.
182. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
183. Savonenko A.V., Melnikova T., Laird F.M., Stewart K.A., Price D.L., Wong P.C. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci U S A 2008, 105:5585-5590.
184. Shaikh S., Collier D., Arranz M., Ball D., Gill M., Kerwin R. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994, 343:1045-1046.
185. Sebat J., Levy D.L., McCarthy S.E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 2009, 25:528-535.
186. Shen S., Lang B., Nakamoto C., Zhang F., Pu J., Kuan S.L., Chatzi C., He S., Mackie I., Brandon N.J., Marquis K.L., Day M., Hurko O., McCaig C.D., Riedel G., St Clair D. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 2008, 28:10893-10904.
187. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008, 4:e28.
188. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
189. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006, 147B:142-148.
190. Siuciak J.A., McCarthy S.A., Chapin D.S., Martin A.N. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl) 2008, 197:115-126.
191. Sobin C., Kiley-Brabeck K., Daniels S., Khuri J., Taylor L., Blundell M., Anyane-Yeboa K., Karayiorgou M. Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis. Child Neuropsychol 2005, 11:39-53.
192. Sobin C., Kiley-Brabeck K., Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry 2005, 162:1090-1099.
193. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16.
194. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., Wan X., Pavlidis P., Mills A.A., Karayiorgou M., Gogos J.A. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 2008, 40:751-760.
195. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
196. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di F.M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
197. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71:877-892.
198. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71:337-348.
199. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192.
200. Suzuki G., Harper K.M., Hiramoto T., Sawamura T., Lee M., Kang G., Tanigaki K., Buell M., Geyer M.A., Trimble W.S., Agatsuma S., Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum Mol Genet 2009, 18:1652-1660.
201. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 2003, 302:1412-1415.
202. Szeszko P.R., Hodgkinson C.A., Robinson D.G., DeRosse P., Bilder R.M., Lencz T., Burdick K.E., Napolitano B., Betensky J.D., Kane J.M., Goldman D., Malhotra A.K. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol 2008, 79:103-110.
203. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Südhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
204. Tachikawa H., Harada S., Kawanishi Y., Okubo T., Suzuki T. Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia. Psychiatry Res 2001, 103:147-155.
205. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am J Psychiatry 2010, 167:1178-1193.
206. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res 2008, 100:4-19.
207. Tsutsumi M., Claus T.H., Liang Y., Li Y., Yang L., Zhu J., Dela Cruz F., Peng X., Chen H., Yung S.L., Hamren S., Livingston J.N., Pan C.Q. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes 2002, 51:1453-1460.
208. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., Thompson K.R., Gradinaru V., Ramakrishnan C., Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
209. Vacic V., McCarthy S., Malhotra D., Murray F., Chou H.H., Peoples A., Makarov V., Yoon S., Bhandari A., Corominas R., Iakoucheva L.M., Krastoshevsky O., Krause V., Larach-Walters V., Welsh D.K., Craig D., Kelsoe J.R., Gershon E.S., Leal S.M., Dell Aquila M., Morris D.W., Gill M., Corvin A., Insel P.A., McClellan J., King M.C., Karayiorgou M., Levy D.L., DeLisi L.E., Sebat J. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011, 471:499-503.
210. Vassar R., Kovacs D.M., Yan R., Wong P.C. The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 2009, 29:12787-12794.
211. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
212. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., Leach R.J., Almasy L., Escamilla M., Raventos H. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 2006, 60:548-553.
213. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron 2003, 38:915-928.
214. Webber M.A., Marder S.R. Better pharmacotherapy for schizophrenia: what does the future hold?. Curr Psychiatry Rep 2008, 10:352-358.
215. Weinberger D.R. From neuropathology to neurodevelopment. Lancet 1995, 346:552-557.
216. Weiss J., Mägert H.J., Cieslak A., Forssmann W.G. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Eur J Med Res 1996, 1:439-445.
217. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., Yin D.M., Lai C., Terry A.V., Vazdarjanova A., Xiong W.C., Mei L. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 2010, 107:1211-1216.
218. Westfall J.E., Hoyt C., Liu Q., Hsiao Y.C., Pierce E.A., Page-McCaw P.S., Ferland R.J. Retinal degeneration and failure of photoreceptor outer segment formation in mice with targeted deletion of the Joubert syndrome gene, Ahi1. J Neurosci 2010, 30:8759-8768.
219. Williams J., Spurlock G., McGuffin P., Mallet J., Nöthen M.M., Gill M., Aschauer H., Nylander P.O., Macciardi F., Owen M.J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996, 347:1294-1296.
220. Woodin M., Wang P.P., Aleman D., Donald-McGinn D., Zackai E., Moss E. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 2001, 3:34-39.
221. Wu J., Li J., Huang K.P., Huang F.L. Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse. J Biol Chem 2002, 277:19498-19505.
222. Xu B., Roos J.L., Dexheimer P., Boone B., Plummer B., Levy S., Gogos J.A., Karayiorgou M. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011, in press.
223. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008, 40:880-885.
224. Xu B., Woodroffe A., Rodriguez-Murillo L., Roos J.L., van Rensburg E.J., Abecasis G.R., Gogos J.A., Karayiorgou M. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci U S A 2009, 106:16746-16751.
225. Xu X., Yang H., Lin Y.F., Li X., Cape A., Ressler K.J., Li S., Li X.J. Neuronal Abelson helper integration site-1 (Ahi1) deficiency in mice alters TrkB signaling with a depressive phenotype. Proc Natl Acad Sci U S A 2010, 107:19126-19131.
226. Yamamoto Y., Akiyoshi J., Kiyota A., Katsuragi S., Tsutsumi T., Isogawa K., Nagayama H. Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor. Brain Res Bull 2000, 53:789-792.
227. Yavich L., Forsberg M.M., Karayiorgou M., Gogos J.A., Männistö P.T. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007, 27:10196-10209.
228. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9:1142-1149.
229. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., Bear M.F., Tonegawa S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107:617-629.
230. Zhang H.T., Huang Y., Masood A., Stolinski L.R., Li Y., Zhang L., Dlaboga D., Jin S.L., Conti M., O'Donnell J.M. Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 2008, 33:1611-1623.
231. Zhang X., Tochigi M., Ohashi J., Maeda K., Kato T., Okazaki Y., Kato N., Tokunaga K., Sawa A., Sasaki T. Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res 2005, 79:175-180.